Marta Peciña, MD, PhD
Education & Training
Selected Honors & Awards
- Sikora M., Heffernan J., Avery E., Mickey B., Zubieta J.K., Pecina M. Salience Network Functional Connectivity Predictors of Placebo Effects in Major Depression. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Jan;1(1):68-76.
- Pecina M., Bohnert A.S.B., Sikora M., Avery E.T., Langenecker S.A., Mickey B.J., Zubieta J.K.: Association Between Placebo-Activated Neural Systems and Antidepressant Responses. JAMA Psychiatry. 2015. Sep. 30; 72(11):1-8. doi:10.1001/jamapsychiatry.2515.1335.
- Pecina M., Love T., Stohler C., Goldman D, Zubieta JK. Effects of the Mu Opioid Receptor Polymorphism (OPRM1 A118G) on Pain Regulation, Placebo Effects and Associated Personality Trait Measures. Neuropsychopharmacology. 2015 Mar;40(4):957-65.
- Pecina M., Martinez Jauand M., Hodgkinson C., Stohler C., Goldman D, Zubieta JK. FAAHselectively influences placebo effects. Mol Psychiatry. 2014 Mar;19(3):385-91. doi: 10.1038/mp.2013.124. Epub 2013 Sep 17.
- Pecina M, Azhar H, Love TM, Lu T, Fredrickson BL, Stohler CS, Zubieta JK. Personality trait predictors of placebo analgesia and neurobiological correlates. Neuropsychopharmacology. 2013; 38 (4):639-646. PMCID: PMC3572460.
JAMA Psychiatry: Dynamic Feedback Between Antidepressant Placebo Expectancies and Mood
Marta Peciña, MD, PhD (Associate Professor of Psychiatry), conducts research focused on the mechanisms of antidepressant treatment response, and uses placebos to investigate how expectancies and learning mechanisms impact mood improvement. In a recent paper published in JAMA Psychiatry, Dr. Peciña and investigators including Alex Dombrovski, MD (Pittsburgh Foundation Endowed Professor in Brain and Mind Research and...
César Escobar-Viera, MD, PhD; Nadine Melhem, PhD; Marta Peciña, MD, PhD; & Collaborators Receive Pitt Momentum Fund Award
A team of investigators from Pitt Psychiatry, César Escobar-Viera, MD, PhD; Nadine Melhem, PhD; and Marta Peciña, MD, PhD, in collaboration with colleagues from the University of Pittsburgh Schools of Education, Public Health, and Arts and Sciences, have received a University of Pittsburgh Momentum Fund Award for their project, “Examining Psychosocial Correlates of Loneliness and Perceived Isolation Among...
Pitt Psychiatry News from the 2022 American College of Neuropsychopharmacology Annual Meeting
Many Pitt Psychiatry faculty and trainees traveled to Phoenix—or participated remotely—for the 2022 American College of Neuropsychopharmacology (ACNP) annual meeting in early December! Below is Pitt Psychiatry news from the meeting: President’s Plenary Marta Peciña, MD, PhD (Associate Professor of Psychiatry), was selected as a President’s Plenary presenter, and discussed the latest work on endogenous opioid...
Magnetic Resonance Imaging Predictors of Pharmacotherapy Response in Major Depressive Disorder
Major depressive disorder is among the most prevalent psychiatric disorders, affecting nearly 300 million people worldwide, and exacting a substantial personal, social, and economic toll. Antidepressant treatment typically involves an individualized trial-and-error approach with an inconsistent success rate. Given the negative outcomes associated with depression, there is a pressing need for the development of...